Katherine Fuh, MD, PhD

Associate Professor
Ob/Gyn, Reproductive Sciences
[email protected]
Research Overview: 

We utilize patient-derived and mouse models to study treatment resistance and metastasis. We also utilize clinical trial specimens to perform translational research to better understand response to new therapies.

Primary Thematic Area: 
Cancer Biology & Cell Signaling
Secondary Thematic Area: 
Immunology
Research Summary: 
Developing targeted treatments in ovarian and endometrial cancer by incorporating the tumor microenvironment.

Websites

Publications: 

A RAD18-UBC13-PALB2-RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cells.

Nucleic acids research

Cybulla E, Wallace S, Meroni A, Jackson J, Agashe S, Tennakoon M, Limbu M, Quinet A, Lomonosova E, Noia H, Tirman S, Wood M, Lemacon D, Fuh K, Zou L, Vindigni A

A toolkit for a modern gynecologic oncology tissue bank.

Gynecologic oncology

Graham O, Rodriguez J, Abbott R, Lomonosova E, Fashemi B, Drexler R, Grither W, Rodriguez K, Compadre A, Loeb M, Sanders B, Kuroki L, Hagemann AR, McCourt C, Thaker PH, Fuh K, Powell MA, Hagemann IS, Mutch DG, Khabele D, Mullen MM

Updates in the Use of Targeted Therapies for Gynecologic Cancers.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Cantillo E, Blanc-Durand F, Leary A, Slomovitz BM, Fuh K, Washington C

Endometrial cancer at recurrence: To re-sequence or not to re-sequence.

Gynecologic oncology reports

Fuh K, Manning-Geist BL

ROR2/Wnt5a Signaling Regulates Directional Cell Migration and Early Tumor Cell Invasion in Ovarian Cancer.

Molecular cancer research : MCR

Grither WR, Baker B, Morikis VA, Ilagan MXG, Fuh KC, Longmore GD